Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2

Affiliations

• ¹ Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, EU, France. paul.bastard@institutimagine.org.
• ² University of Paris, Imagine Institute, Paris, EU, France. paul.bastard@institutimagine.org.
• ³ St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. paul.bastard@institutimagine.org.
• ⁴ Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, EU, France.
• ⁵ University of Paris, Imagine Institute, Paris, EU, France.
• ⁶ Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, AP-HP, Paris, EU, France.
• ⁷ Service de Médecine Interne, Centre de Référence Maladies Auto-immunes et Systémiques Rares d'Ile de France, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (APHP), Paris, EU, France.
• ⁸ APHP-CUP, Hôpital Cochin, Université de Paris, Paris, EU, France.
• ⁹ Pediatric Dermatology Unit, Necker Hospital for Sick Children, AP-HP, Paris, EU, France.
• ¹⁰ Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, EU, France. jean-laurent.casanova@rockefeller.edu.
• ¹¹ University of Paris, Imagine Institute, Paris, EU, France. jean-laurent.casanova@rockefeller.edu.
• ¹² St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. jean-laurent.casanova@rockefeller.edu.
• ¹³ Howard Hughes Medical Institute, New York, NY, USA. jean-laurent.casanova@rockefeller.edu.